The thesis

D-Wave sells quantum annealing systems for optimization problems, positioned as a direct beneficiary of the AI capex cycle and a May 2026 federal quantum investment announcement. Conviction sits at 67 out of 100, high tier, driven almost entirely by macro tailwind scoring rather than operating performance. Revenue growth is negative 81% year over year. Net margin is negative 2957%, and P/E is negative 16.2x — there is no earnings base to value this against. The gross margin figures reported are wildly inconsistent, ranging from 83% GAAP in the company description to 6627% in the financial summary, a sign the underlying revenue base is too small and volatile for standard ratios to hold meaning.

Why now

The stock is trading on policy catalysts, not fundamentals — the May 2026 federal quantum investment announcement is the kind of headline that has driven 30%+ single-day moves in this name before. Analyst consensus is BUY despite a DCF intrinsic value of effectively zero, meaning the current price is a bet on narrative continuation, not discounted cash flows.

What to watch

Watch quarterly revenue trend for signs the 81% decline is bottoming, and watch for contract announcements tied to the federal quantum investment program post-May 2026. Any analyst downgrade from BUY, or a stretch without policy headlines, would be an early signal the narrative-driven premium is fading.

Key risks

Commercial revenue is very limited, so any pullback in policy attention or AI capex sentiment removes the primary support for the stock. The 81% revenue decline year over year raises real execution risk — if bookings or contract wins don't reverse this within the next few quarters, the AI-beneficiary narrative loses its factual anchor. Valuation has no fundamental floor: negative P/E, negative net margin near -2957%, and a DCF value of roughly zero mean the stock's price is disconnected from any conventional model.

Theme exposure